MED19 and prostate cancer: To determine if MED19 is sufficient to convert androgen-dependent prostate cancer cells to androgen independence, we stably overexpressed MED19 by lentiviral transduction in the prototypical androgen-dependent LNCaP cell line (MED19 LNCaP cells) (S1 Fig).